Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer

Muscle Invasive Bladder Cancer (MIBC) has a poor prognosis. Whilst patients can achieve a 6% improvement in overall survival with Neo-Adjuvant Chemotherapy (NAC), many do not respond. Body fluid mutant DNA (mutDNA) may allow non-invasive identification of treatment failure. We collected 248 liquid b...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, K. M., van der Vos, K. E., Smith, C. G., Mouliere, F., Tsui, D., Morris, J., Chandrananda, D., Marass, F., van den Broek, D., Neal, D. E., Gnanapragasam, V. J., Forshew, T., van Rhijn, B. W., Massie, C. E., Rosenfeld, N., van der Heijden, M. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514073/
https://www.ncbi.nlm.nih.gov/pubmed/28717136
http://dx.doi.org/10.1038/s41598-017-05623-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514073/
https://www.ncbi.nlm.nih.gov/pubmed/28717136
http://dx.doi.org/10.1038/s41598-017-05623-3

Ejemplares similares